DUBLIN, Dec 8, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Wound Debridement Products - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Wound Debridement Products in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
Company profiles are primarily based on public domain information including company URLs. The report profiles 30 companies including many key and niche players such as -
Advanced Medical Solutions Group plc
Coloplast A/S
Derma Sciences, Inc.
Lohmann & Rauscher GmbH
Misonix, Inc.
Key Topics Covered:
1. INDUSTRY OVERVIEW
- Wound Debridement
- Market Overview
- Outlook
- Chronic Wounds and Healthcare Burden
- Chronic Wounds: The Hard Numbers
- Prevalence and Incidence of Wounds
- Select Statistics
- Growing Incidence of Hard to Heal Wounds Drives Market for Debridement Products
- Maintenance Debridement Sustains Adoption of Debridement Products/Techniques
- Competition
- Leading Players in the Global Wound Debridement Products Market
- Wound Debridement Devices
2. MARKET TRENDS AND DRIVERS
- Companies Gear up Focus on Advanced Products to Address Unmet Needs
- NexoBrid
- EscharEx
- CPI Wound Therapy System
- Jetox Lavage Systems
- Monofilament Polyester Fibre Pads Buoy Growth in Mechanical Debridement Market
- Plasma-Mediated Bipolar Radio Frequency Ablation Demonstrates Selective Ablation
- Hydrosurgery Emerges as a Safe and Cost Effective Method
- Ultrasound Emerges as a Viable Option to Promote Improved Wound Healing
- Focus Grows on More Effective and Less Painful Debridement Techniques for Burn Patients
- Debridement
- An Important Prevention Tool for Chronic wounds in Diabetic Patients
- Honey as a Debridement Agent Gains Prominence
- Larvae Therapy Re-Emerges as an Effective Debridement Technology
- Increasing Focus on Reducing Hospital Stays Lends Traction
3. GENERAL GROWTH DRIVERS
- Expanding Aging Population Spurs Demand
- Rising Prevalence of Diabetes Escalates Incidence of Chronic Wounds
- Increasing Obesity Levels Underpins Market Growth
4. PRODUCT OVERVIEW
5. STRATEGIC CORPORATE DEVELOPMENTS
- Lohmann & Rauscher Introduces Debrisoft® Lolly
- Misonix Introduces SonicVac based on LFDCU Debridement Technology
- Topigenix Launches Topigenix Wound Care Line
- EscharEx® from MediWound Completes Phase II Clinical Trial
- Misonix Introduces Sonicone® Ultrasonic Debridement Procedure
- Lohmann & Rauscher Launches Debrisoft® Active Monofilament Debriding Device
- BioMonde Introduces BioBag for treatment of Chronic Wounds
- Oculus Enters into Partnership with Genetix Biotech to Introduce Wound care Products in India
- MediWound Commences U.S. Phase 3 Trial with NexoBrid for Treatment of Thermal Burns
6. FOCUS ON SELECT GLOBAL PLAYERS
7. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 30 (including Divisions/Subsidiaries 39)
- The United States (26)
- Canada (2)
- Europe (9)
- - Germany (2)
- - The United Kingdom (5)
- - Rest of Europe (2)
- Asia-Pacific (Excluding Japan) (1)
- Middle-East (1)
For more information about this report visit http://www.researchandmarkets.com/research/t3lttr/wound_debridement
Media Contact:
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
